Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption

被引:59
作者
Yi, Jae-Sung [1 ]
Choo, Hyo-Jung [1 ]
Cho, Bong-Rae [2 ]
Kim, Hwan-Myung [3 ]
Kim, Yong-Nyun [4 ]
Ham, Young-Mi [1 ]
Ko, Young-Gyu [1 ]
机构
[1] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea
[2] Korea Univ, Dept Chem, Seoul 136701, South Korea
[3] Ajou Univ, Dept Chem, Suwon 443749, Kyunggi Do, South Korea
[4] Natl Canc Ctr, Div Specif Organs Ctr, Kyonggi Do 411769, South Korea
关键词
Lipid rafts; Ginsenoside Rh2; Fas activation; Apoptosis; CANCER CELLS; CHOLESTEROL; MEMBRANE; CYTOTOXICITY; APOPTOSIS; CAVEOLAE; STATINS; TRIALS; GROWTH; RH-2;
D O I
10.1016/j.bbrc.2009.05.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This results suggests that Rh2 is a novel lipid rift disruptor leading to Fas oligomerization and apoptosis. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 159
页数:6
相关论文
共 31 条
[1]   Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer - Insights from large randomized statin trials [J].
Alsheikh-Ali, Alawi A. ;
Maddukuri, Prasad V. ;
Han, Hui ;
Karas, Richard H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) :409-418
[2]   Gli and hedgehog in cancer:: Tumours, embryos and stem cells [J].
Altaba, AR ;
Sánchez, P ;
Dahmane, N .
NATURE REVIEWS CANCER, 2002, 2 (05) :361-372
[3]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[4]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[5]  
Bocan Thomas M A, 2002, Curr Opin Investig Drugs, V3, P1312
[6]   Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies [J].
Bonovas, S ;
Filioussi, K ;
Tsavaris, N ;
Sitaras, NM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8606-8612
[7]   Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells [J].
Cheng, CC ;
Yang, SM ;
Huang, CY ;
Chen, JC ;
Chang, WM ;
Hsu, SL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :531-540
[8]  
Fei XF, 2002, ACTA PHARMACOL SIN, V23, P315
[9]   HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR? [J].
Freeman, MR .
CANCER CELL, 2004, 6 (05) :427-428
[10]   Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis [J].
Gniadecki, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (01) :165-169